Answer
For the SERB indigo carmine product, excretion of indigo carmine or its metabolites into human milk is unknown; risk to the breastfed child cannot be excluded, so stopping breastfeeding or withholding treatment must be decided by weighing benefits for the child and woman.
Sources for this answer
- Indigo carmine 40 mg/5 mL, solution for injectionSERB · emc · SmPC §4.6 Fertility, pregnancy and lactation · Version 3Document updated
Sources checked